436 related articles for article (PubMed ID: 25676338)
1. Neuroprotection in the treatment of glaucoma--A focus on connexin43 gap junction channel blockers.
Chen YS; Green CR; Danesh-Meyer HV; Rupenthal ID
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):182-93. PubMed ID: 25676338
[TBL] [Abstract][Full Text] [Related]
2. Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma.
Lambiase A; Aloe L; Centofanti M; Parisi V; Báo SN; Mantelli F; Colafrancesco V; Manni GL; Bucci MG; Bonini S; Levi-Montalcini R
Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13469-74. PubMed ID: 19805021
[TBL] [Abstract][Full Text] [Related]
3. Disease progression and the need for neuroprotection in glaucoma management.
Varma R; Peeples P; Walt JG; Bramley TJ
Am J Manag Care; 2008 Feb; 14(1 Suppl):S15-9. PubMed ID: 18284311
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel inhibitors for the treatment of glaucoma.
Cholkar K; Trinh HM; Pal D; Mitra AK
Expert Opin Drug Discov; 2015 Mar; 10(3):293-313. PubMed ID: 25575654
[TBL] [Abstract][Full Text] [Related]
5. Current and emerging medical therapies in the treatment of glaucoma.
Bagnis A; Papadia M; Scotto R; Traverso CE
Expert Opin Emerg Drugs; 2011 Jun; 16(2):293-307. PubMed ID: 21406029
[TBL] [Abstract][Full Text] [Related]
6. Molecular and cell-based approaches for neuroprotection in glaucoma.
Lebrun-Julien F; Di Polo A
Optom Vis Sci; 2008 Jun; 85(6):417-24. PubMed ID: 18521011
[TBL] [Abstract][Full Text] [Related]
7. [The dawn of neuroprotective therapy for glaucomatous optic neuropathy].
Yamamoto T
Nippon Ganka Gakkai Zasshi; 2001 Dec; 105(12):866-83. PubMed ID: 11802458
[TBL] [Abstract][Full Text] [Related]
8. [Aiming for zero blindness].
Nakazawa T
Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
[TBL] [Abstract][Full Text] [Related]
9. The arguments for and against cannabinoids application in glaucomatous retinopathy.
Panahi Y; Manayi A; Nikan M; Vazirian M
Biomed Pharmacother; 2017 Feb; 86():620-627. PubMed ID: 28027538
[TBL] [Abstract][Full Text] [Related]
10. Leptin as a neuroprotective agent in glaucoma.
Gupta A
Med Hypotheses; 2013 Nov; 81(5):797-802. PubMed ID: 24035688
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma.
Jiang C; Moore MJ; Zhang X; Klassen H; Langer R; Young M
Mol Vis; 2007 Sep; 13():1783-92. PubMed ID: 17960131
[TBL] [Abstract][Full Text] [Related]
12. Is neuroprotection a viable therapy for glaucoma?
Weinreb RN; Levin LA
Arch Ophthalmol; 1999 Nov; 117(11):1540-4. PubMed ID: 10565524
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective Effect of Statins in a Rat Model of Chronic Ocular Hypertension.
Kim ML; Sung KR; Kwon J; Choi GW; Shin JA
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830387
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma.
Hains BC; Waxman SG
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4164-9. PubMed ID: 16249495
[TBL] [Abstract][Full Text] [Related]
15. Structural and functional neuroprotection in glaucoma: role of galantamine-mediated activation of muscarinic acetylcholine receptors.
Almasieh M; Zhou Y; Kelly ME; Casanova C; Di Polo A
Cell Death Dis; 2010; 1(2):e27. PubMed ID: 21364635
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotection in glaucoma - Is there a future role?
Baltmr A; Duggan J; Nizari S; Salt TE; Cordeiro MF
Exp Eye Res; 2010 Nov; 91(5):554-66. PubMed ID: 20800593
[TBL] [Abstract][Full Text] [Related]
17. Review of rodent hypertensive glaucoma models.
Biswas S; Wan KH
Acta Ophthalmol; 2019 May; 97(3):e331-e340. PubMed ID: 30549197
[TBL] [Abstract][Full Text] [Related]
18. [Retinal ganglion cells death in glaucoma--mechanism and potential treatment. Part I].
Rokicki W; Dorecka M; Romaniuk W
Klin Oczna; 2007; 109(7-9):349-52. PubMed ID: 18260296
[TBL] [Abstract][Full Text] [Related]
19. Glaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancement.
Chang EE; Goldberg JL
Ophthalmology; 2012 May; 119(5):979-86. PubMed ID: 22349567
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice.
Zhong L; Bradley J; Schubert W; Ahmed E; Adamis AP; Shima DT; Robinson GS; Ng YS
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1212-8. PubMed ID: 17325165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
